Investigation of treatment volume versus circulating blood volume during Rheocarna treatment.

Yuki HoshikawaAtsushi OhkuboTakatoshi SakurasawaMana UsuiMasaya DeushiHiroko YamamotoShotaro Naito

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2024)

The results reveal that a treatment volume of 1.5 times the circulating blood volume is a sufficient solute removal capacity in the Rheocarna-enabled cases.

Keyphrases

combination therapy
genome wide
single cell
replacement therapy